| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Savvidou, E Jennions, S Wikström, M Olsson-Engman, K Sofou, N Dari. Drug-induced hyperthermia with rhabdomyolysis in CLN3 disease. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 39. 2022-06-18. PMID:35716526. |
neuroleptic malignant syndrome (nms) has previously been described in two patients with ncl, one with cln3 disease and one with adult onset ncl of unclear genetic origin. |
2022-06-18 |
2023-08-14 |
Not clear |
| Saba Zaidi, Nashit Irfan, Zain Khali. Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. vol 32. issue 4. 2022-05-28. PMID:35633010. |
neuroleptic malignant syndrome (nms) was initially notified as an adverse effect of an antipsychotic agent called chlorpromazine, in 1956. |
2022-05-28 |
2023-08-13 |
Not clear |
| Ling Deng, Zhi-Xin Qiu, Mao-Yun Wan. Risperidone-induced neuroleptic malignant syndrome: a case report. Therapeutic advances in psychopharmacology. vol 12. 2022-05-19. PMID:35586306. |
neuroleptic malignant syndrome (nms) is a rare illness that results from reactions to antipsychotics. |
2022-05-19 |
2023-08-13 |
Not clear |
| Tomohito Mizuno, Riku Takahashi, Takahiro Kamiyama, Atsushi Suzuki, Masashi Suzuk. Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report. The American journal of case reports. vol 23. 2022-05-06. PMID:35514081. |
we report a case of neuroleptic malignant syndrome (nms) with adrenal insufficiency after initial vaccination with pfizer/biontech bnt162b2. |
2022-05-06 |
2023-08-13 |
Not clear |
| Tanya Paul, Alvina Karam, Trissa Paul, Hanyou Loh, Gerardo F Ferre. A Case Report on Neuroleptic Malignant Syndrome (NMS): How to Approach an Early Diagnosis. Cureus. vol 14. issue 3. 2022-05-04. PMID:35505741. |
a case report on neuroleptic malignant syndrome (nms): how to approach an early diagnosis. |
2022-05-04 |
2023-08-13 |
Not clear |
| Tanya Paul, Alvina Karam, Trissa Paul, Hanyou Loh, Gerardo F Ferre. A Case Report on Neuroleptic Malignant Syndrome (NMS): How to Approach an Early Diagnosis. Cureus. vol 14. issue 3. 2022-05-04. PMID:35505741. |
neuroleptic malignant syndrome (nms) is a life-threatening neurological emergency that has been observed to occur in some patients following the administration of anti-dopaminergic agents or the rapid withdrawal of dopaminergic medications. |
2022-05-04 |
2023-08-13 |
Not clear |
| Haruka Takenouchi, Takatoshi Anno, Yukiko Kimura, Fumiko Kawasaki, Ryo Shirai, Hideaki Kaneto, Katsumi Kurokawa, Koichi Tomod. Case Report: A Patient With Neuroleptic Malignant Syndrome, Water Intoxication and Hyponatremia Associated With Severe Cerebral Edema and Coma. Frontiers in endocrinology. vol 13. 2022-04-01. PMID:35360072. |
neuroleptic malignant syndrome (nms) is a serious complication induced by administration of antipsychotics and other psychotropic drugs. |
2022-04-01 |
2023-08-13 |
Not clear |
| Chi-Ju Yang, Ching-Tang Chiu, Yu-Chang Yeh, Anne Cha. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World journal of clinical cases. vol 10. issue 2. 2022-01-31. PMID:35097088. |
we report a case of lorazepam-induced agitated delirium treated with haloperidol, which in turn triggered the onset of neuroleptic malignant syndrome (nms). |
2022-01-31 |
2023-08-13 |
Not clear |
| Alexander Ionov, Inger Boeck, Stefan Georg Schröde. [Electroconvulsive Therapy (ECT) in Neuroleptic Malignant Syndrome (NMS) on an Intensive Care Unit (ICU)]. Psychiatrische Praxis. 2022-01-26. PMID:35081629. |
[electroconvulsive therapy (ect) in neuroleptic malignant syndrome (nms) on an intensive care unit (icu)]. |
2022-01-26 |
2023-08-13 |
Not clear |
| Alexander Ionov, Inger Boeck, Stefan Georg Schröde. [Electroconvulsive Therapy (ECT) in Neuroleptic Malignant Syndrome (NMS) on an Intensive Care Unit (ICU)]. Psychiatrische Praxis. 2022-01-26. PMID:35081629. |
the icu's call to the mh hotline did not give a hint to consider a neuroleptic malignant syndrome (nms) neither to consider electroconvulsive therapy (ect). |
2022-01-26 |
2023-08-13 |
Not clear |
| Stefano Berloffa, Claudia Dosi, Benedetta Tascini, Beatrice Fossati, Ilaria Lupetti, Gabriele Mas. Neuroleptic Malignant Syndrome in Children with Autism Spectrum Disorder (ASD): A Case Report and Brief Review of Recent Literature. Children (Basel, Switzerland). vol 8. issue 12. 2021-12-24. PMID:34943397. |
neuroleptic malignant syndrome (nms) is a rare, life-threatening, idiosyncratic adverse reaction to antipsychotic drugs. |
2021-12-24 |
2023-08-13 |
Not clear |
| Robert Joseph C Sarmiento, Jose Danilo B Diestro, Athena Kate D Antonio, Mario B Prado, Karen Joy B Adiao, Carissa Paz Dioquino-Maligas. Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature. The Neurohospitalist. vol 12. issue 1. 2021-12-24. PMID:34950391. |
anti-n-methyl-d-aspartate receptor (nmdar) encephalitis is a severe but treatable disease that presents with symptoms similar to neuroleptic malignant syndrome (nms). |
2021-12-24 |
2023-08-13 |
Not clear |
| Ryou Izumiya, Yasuhiko Fujita, Teruyoshi Amaga. A case of influenza-associated invasive aspergillosis with cerebral hemorrhage due to infectious vasculopathy. Radiology case reports. vol 17. issue 2. 2021-12-11. PMID:34876959. |
by contrast, neuroleptic malignant syndrome (nms) occurs rarely in psychiatric patients who are treated with olanzapine. |
2021-12-11 |
2023-08-13 |
Not clear |
| Daniel Guinart, Heidi Taipale, Jose M Rubio, Antti Tanskanen, Christoph U Correll, Jari Tiihonen, John M Kan. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort. Schizophrenia bulletin. vol 47. issue 6. 2021-12-02. PMID:34013325. |
long-acting injectable antipsychotics (lais) are associated with multiple positive outcomes in psychosis, but it is unclear whether lais are associated with worse outcomes if neuroleptic malignant syndrome (nms), a potentially lethal adverse effect, occurs. |
2021-12-02 |
2023-08-13 |
Not clear |
| Deborah León-Amenero, Jeff Huarcaya-Victori. Neuroleptic malignant syndrome in children and adolescents: Systematic review of case reports. Revista Colombiana de psiquiatria (English ed.). vol 50. issue 4. 2021-11-25. PMID:34742696. |
neuroleptic malignant syndrome (nms) is a rare and potentially fatal drug adverse reaction. |
2021-11-25 |
2023-08-13 |
Not clear |
| Joseph H Friedma. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Parkinsonism & related disorders. vol 79. 2021-11-15. PMID:32871538. |
these include: acute onset disorders: dystonic reactions, akathisia and the neuroleptic malignant syndrome (nms); non-acute onset parkinsonism; and the tardive syndromes. |
2021-11-15 |
2023-08-13 |
Not clear |
| Mandeep Rana, Karen Cuttin, Gerard T Berry, Alcy Torre. Paroxysmal hyperthermia, dysautonomia and rhabdomyolysis in a patient with Lesch-Nyhan syndrome. JIMD reports. vol 62. issue 1. 2021-11-13. PMID:34765395. |
our patient presented similarly to that of a patient with neuroleptic malignant syndrome (nms), with symptoms including altered mental status, fever, dysautonomia and renal failure, and laboratory findings including elevated serum creatinine kinase, leukocytosis, transaminitis, hypernatremia and metabolic acidosis. |
2021-11-13 |
2023-08-13 |
Not clear |
| Seung Yeon Rhee, Hyoung Seop Ki. Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Case Report. Clinical neuropharmacology. vol 44. issue 2. 2021-10-25. PMID:33560007. |
neuroleptic malignant syndrome (nms) is a reversible, idiosyncratic, and potentially life-threatening reaction, which is usually caused by antipsychotics and other agents, such as mood stabilizers (eg, lithium and metoclopramide). |
2021-10-25 |
2023-08-13 |
Not clear |
| Kim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, Lam Lam, Ian C K Wong, Frank M C Besag, Wing Chung Chang, David J Castle, Esther W Cha. Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover Study. CNS drugs. vol 34. issue 11. 2021-10-20. PMID:33010024. |
neuroleptic malignant syndrome (nms) is a rare and acute adverse drug reaction associated with antipsychotic therapy. |
2021-10-20 |
2023-08-13 |
Not clear |
| b' Julija \\xc4\\x8ciau\\xc5\\xa1kait\\xc4\\x97, Ieva Puleikyt\\xc4\\x97, Simonas Jesmanas, Giedr\\xc4\\x97 Jurkevi\\xc4\\x8dien\\xc4\\x97, Antanas Vaitkus, Daiva Rastenyt\\xc4\\x9. Creutzfeldt-Jakob disease with neuroleptic malignant syndrome. Clinical case reports. vol 9. issue 8. 2021-10-18. PMID:34466255.' |
neuroleptic malignant syndrome (nms) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of cjd. |
2021-10-18 |
2023-08-13 |
Not clear |